Company & Sponsor Intelligence

Peking Union Medical College Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting1

Completed1

Countries1

Therapeutic footprint

epilepsyneuromuscularstroke

Indexed studies

NCT03356769Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
epilepsy · ChinaPHASE2

NCT07475754A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy
neuromuscular · NA

NCT03167346The Investigation of Public Awareness of Core Stroke Symptoms
stroke · ChinaCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →